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Abstract
This paper reviews the very large discrepancies in pregnancy outcomes between high, low and middle-income
countries and then presents the medical causes of maternal mortality, stillbirth and neonatal mortality in low-and
middle-income countries. Next, we explore the medical interventions that were associated with the very rapid and very
large declines in maternal, fetal and neonatal mortality rates in the last eight decades in high-income countries. The
medical interventions likely to achieve similar declines in pregnancy-related mortality in low-income countries are
considered. Finally, the quality of providers and the data to be collected necessary to achieve these reductions are
discussed. It is emphasized that single interventions are unlikely to achieve important reductions in pregnancy-related
mortality. Instead, improving the overall quality of pregnancy-related care across the health-care system will be
necessary. The conditions that cause maternal mortality also cause stillbirths and neonatal deaths. Focusing on all three
mortalities together is likely to have a larger impact than focusing on one of the mortalities alone.
Keywords: Maternal mortality, Stillbirth, Neonatal mortality, Low-middle income countries
Background
Maternal mortality is generally defined as death to the
mother during pregnancy or during the first 42 days
after birth. In low and some middle-income countries,
maternal mortality rates are 50 to 100-fold higher than
those seen in high-income countries [1, 2]. Stillbirth is
defined as death in utero after 20 to 28 weeks of preg-
nancy, depending on where the birth occurs [3, 4]. In
low-income countries, stillbirth rates are ten to 20-fold
higher than those rates seen in high income-countries.
Neonatal mortality is defined as death to a live-born
baby within 28 days of birth [5, 6]. The neonatal mortal-
ity rates in low and middle-income countries are often
tenfold the rates in high-income countries. Many
current low-income country mortality rates are similar
to the rates in high-income countries from the early
1900’s. This paper first explores the causes of maternal
mortality, stillbirth and neonatal death, and then con-
siders why the rates of each outcome have improved in
high-income countries. Finally, we review recommenda-
tions regarding interventions to reduce these mortalities
in low- and middle-income countries.
Etiology of maternal mortality
In most low and some middle-income countries, the
causes of maternal mortality include hemorrhage, hyper-
tensive diseases and maternal infections [7–11]. The
timing of hemorrhage is often divided between the ante-
partum and post-partum periods. The most common
cause of antenatal hemorrhage is placental abruption.
The most common cause of post-partum hemorrhage is
uterine atony. Hypertensive diseases are another cause
of maternal mortality. In the first pregnancy compared
to subsequent pregnancies, women are at higher risk to
develop preeclampsia, a condition marked by hyperten-
sion and proteinuria, that may lead to complications in-
cluding seizures and strokes. If seizures are associated
with preeclampsia, the condition is known as eclampsia.
Infections contribute to maternal death, but the extent
in low and middle-income countries is often not clear.
In some classification systems, obstructed labor is not
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considered a cause of death, with the death generally as-
cribed to infection or hemorrhage [12]. When women
who have an unsafe abortion die, the cause of death is
usually defined as either hemorrhage or infection.
Etiology of stillbirth
For international comparisons of stillbirth rates, the
World Health Organization (WHO) recommends using
a lower gestational age cutoff of 28 weeks, although in
the US and many other high-income countries, lower
gestational age cutoffs from 20 to 26 weeks often are
used to define stillbirth [3, 13, 14]. In the US, about half
of all stillbirths occur at less than 28 weeks [15]; how-
ever, this proportion is unknown for low and many
middle-income countries. In this paper, we use the terms
fetal death and stillbirth interchangeably. In general, we
have used the WHO definition that considers stillbirths
at 28 weeks gestation or more. In some low and middle-
income countries, especially in sub-Saharan Africa, mal-
aria and syphilis are important contributors to stillbirth.
However, most fetal deaths are due to asphyxia. Mater-
nal hypertensive diseases, abruption, prolonged labor,
breech presentation and umbilical cord accidents are
often precursors to asphyxia-related stillbirth [16–21].
Etiology of neonatal deaths
Neonatal mortality in low and middle-income countries
is caused by three major conditions: asphyxia, infection
and prematurity [21–23]. Birth asphyxia is usually
caused by a maternal condition such as obstructed labor
or a placental abruption. Neonatal infections are often
associated with maternal infection and are acquired pre-
natally, although nosocomial infections acquired in the
nursery are common. In recent years, it has become
clear that prematurity is not the primary cause of neo-
natal death, but prematurity-related conditions such as
respiratory distress syndrome (RDS), a condition caused
by failure to produce sufficient quantities of lung surfac-
tant, intraventricular hemorrhage (IVH) or bleeding into
the newborn’s brain, and necrotizing enterocolitis (NEC)
or breakdown of the infant’s bowel, as well as infection
and asphyxia actually cause most of the deaths [22]. Ap-
propriately assigning cause of death for preterm infants
is an important step to designing interventions to im-
prove outcomes in preterm infants.
History of pregnancy outcome improvements in high
income countries
There have been large reductions in maternal, fetal and
neonatal mortality in high-income and many middle-
income countries over the last decades [23–26]. In these
countries, until about 1935, maternal mortality ranged from
500 to 1000 deaths per 100,000 live births. Thus, nearly 1%
of all mothers died during pregnancy [25]. In recent years,
many high-income countries have reported maternal mor-
tality ratios of 10 per 100,000 live births or less [1, 2, 25].
Several papers have explored the history of this rapid re-
duction that began in about 1935 and was mostly com-
pleted by 1970–1980 in nearly all high-income countries.
In the 1930s and 1940s, the important interventions intro-
duced included prenatal care and hospitalization for deliv-
ery, antibiotics to treat infection, uterotonics, and blood
transfusion [26, 27]. Most of the reduction in maternal
mortality prior to about 1950 was due to fewer infection-
related deaths, probably resulting from the availability and
use of antibiotics, although greater attention to infection
prevention may have played a role. Although preeclampsia
diagnostics including blood pressure testing and testing for
proteinuria were made available to many women with the
onset of prenatal care, much of the reduction in preeclamp-
sia/eclampsia-related mortality started around 1950.
Hospitalization for women with severe or progressive dis-
ease became the norm. Not well documented, but probably
extremely important, the management of severe preeclamp-
sia and eclampsia transitioned from observation and sed-
ation to rapid delivery [27]. With availability of antibiotics
and blood, as well as improvements in anesthesia, cesarean
sections became safer and were provided more frequently
to terminate pregnancies with prolonged labor or eclampsia
and other conditions that were life-threatening to the
mother. Thus, beginning in 1935, the introduction of new
interventions was responsible for much of the reduction in
maternal mortality. With these interventions, introduced
first in high-income followed by middle-income countries,
nearly 99% of the maternal mortality was eliminated in
these regions [26].
Since record keeping began, despite various definitions,
in many high-income countries the stillbirth rates approx-
imated 50 per 1000 births [23]. In the 2016 Lancet still-
birth series, most high-income countries reported
stillbirth rates of < 5 per 1000 births [28]. Several Scandi-
navian countries and Japan reported rates around 2 per
1000 births. Stillbirth rates began to fall in the 1930’s and
continued to decline rapidly until about 1980 [23]. Since
1980, the reductions in most countries has been slower.
Because the cause of death for any specific stillbirth is
often difficult to determine, it is also nearly impossible to
accurately define the interventions responsible for the
changes in rates. Nevertheless, some evidence is available.
For example, early in the twentieth century, it was esti-
mated that about 20% of US stillbirths were caused by
syphilis [29]. Today in most developed countries, syphilis
rarely causes a stillbirth but remains a concern in many
low-income countries, especially in sub-Saharan Africa
[30]. In the early twentieth century, preeclampsia and
eclampsia were likely the most important killers of fetuses.
However, today those conditions account for only a small
percentage of a much smaller number of stillbirths [23].
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The risks for stillbirth associated with abruption are much
reduced. Monitoring for fetal asphyxia prenatally and dur-
ing delivery, using various techniques such as fetal heart
rate monitoring, with delivery for signs of distress, has re-
duced much of the asphyxia-related fetal mortality. The
high rates of cesarean section and labor induction in many
high-income countries occur in part to reduce risk of still-
birth. Thus, with appropriate care for the mother, it has
been possible to reduce stillbirth rates substantially [31].
We have also emphasized that the conditions that cause
stillbirths and maternal mortality are similar and the inter-
ventions that reduce maternal mortality will also reduce
stillbirths as well [31, 32].
Neonatal mortality in high-income countries has also
decreased since the middle of the last century. There has
been a decreasing prevalence of some conditions that
cause death but most of the decline is related to better
treatment for many of the conditions. Currently in low
and middle-income countries, most of the neonatal mor-
tality is divided between asphyxia, infection and preterm
birth with a smaller percentage due to congenital anom-
alies [33]. However, when the infection and asphyxia that
occurs in preterm infants is considered, it has been esti-
mated that 60 to 70% of all neonatal deaths occur in pre-
term infants. In high-income countries, the incidence of
preterm birth has remained relatively flat or slightly in-
creased over the last decades, so decreasing rates of pre-
term birth are not the explanation for the decreased
mortality. Preterm infants die from respiratory distress
syndrome (RDS), intraventricular hemorrhage (IVH),
necrotizing enterocolitis (NEC), infection, as well as as-
phyxia [22]. Since the middle of the twentieth century,
the treatment of RDS with oxygen, and later with vari-
ous types of ventilation support including continuous
positive airway pressure (CPAP), and still later, artificial
surfactant, used as either a prevention or treatment, sub-
stantially lowered the death rate from RDS. In high-
income countries beginning in the 1970’s and continuing
through the present, increasing use of maternal cortico-
steroids prior to delivery substantially lowered the inci-
dence of RDS and the associated IVH, NEC and
mortality [34]. The incidence of infection in all neonates
was also reduced with better attention to clean delivery
care and antibiotics used prophylactically. Treatment
with antibiotics for those newborns that did become in-
fected improved. Maternal treatment for syphilis and
vaccination for tetanus has reduced newborn infection-
related mortality. The incidence of newborn asphyxia
was substantially reduced with better obstetric care in-
cluding monitoring for hypoxia prenatally and during
labor, and the increased use of cesarean sections for
signs of fetal distress. Newborn resuscitation techniques
improved and treatment of newborns with birth-related
asphyxia also reduced mortality. Because the care for
preterm and sick newborns became increasingly compli-
cated, it was consolidated in newborn intensive care
units. Thus, as with maternal and fetal mortality, sub-
stantial reductions in neonatal mortality occurred from
about 1940 onward.
Interventions to reduce maternal, fetal and neonatal
mortality
The interventions that are effective in preventing most
maternal, fetal and neonatal deaths in high-income coun-
tries have been well-studied [35]. In theory, if these inter-
ventions were available to pregnant women and their
newborns in low and middle-income countries, pregnancy
related mortality rates should approach those seen in high
and some middle-income countries. New interventions or
technologies should not generally be necessary to achieve
substantial decreases in these mortality rates in low- and
middle-income countries. Instead, the question that arises
is not what needs to be done, but how to introduce these
interventions, ensure their correct use and sustain that
use. For example, it has been observed that even if an
intervention is available, it may be initiated at the wrong
time, poorly implemented or even performed on the
wrong patients [34, 36]. Coverage is important, but quality
is important as well.
While understanding which interventions are likely to
reduce mortality is necessary, ensuring a functioning sys-
tem of care in which to introduce and sustain a group of
interventions is even more important. Single interventions
rarely result in substantial reductions in mortality. In
order to effectively reduce mortality, it is important to
understand the many conditions that cause mortality and
the many interventions likely to reduce the mortality as
well as defining the population to be cared for, and the re-
sources and personnel available to provide that care.
We next review the interventions that many experts be-
lieve should be included in the content of care aimed at
reducing maternal, fetal and neonatal mortality in low and
middle-income countries. To save the life of a mother,
fetus or neonate from a specific condition, the condition
must either be prevented or be diagnosed and treated in
an appropriate and timely manner. Knowing the condi-
tions mothers, fetuses and newborns die from and when
and where they die is therefore crucial. About three quar-
ters of the maternal deaths, about half the stillbirths and
about one-quarter of the neonatal deaths occur around
delivery [33]. Interventions that improve facility-based de-
livery and neonatal care will result in the largest reduc-
tions in maternal, fetal and neonatal mortality [36].
Maternal mortality
Especially in south Asia, anemia during pregnancy is a
major problem and is in part responsible for many, but
an unknown number of deaths. According to data
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derived from the Global Network’s Registry, in the Paki-
stani and Indian sites, nearly all women are anemic with
a hemoglobin level of less than 11 mg/dl, and in
Pakistan, 8 % of the women have a hemoglobin level of
less than 8 mg/dl [personal communication]. In a recent
publication, anemia has been associated with a doubling
of the maternal mortality rate, and low iron levels in the
mother and newborn are associated with decreased neu-
rodevelopmental status in the child [37]. Oral iron and
folate supplementation have been the mainstays of pre-
vention and treatment strategies to reduce anemia.
However, in this supplement, it is argued that since this
strategy is often ineffective, other strategies such as
intravenous iron treatment are necessary to treat anemia
and iron deficiency [38]. It is also important to consider
and appropriately treat other causes of maternal anemia
such as parasitic infestations.
Hemorrhage, the leading cause of maternal mortality
globally, has many different etiologies ranging from an
atonic uterus to retained products of conception to lac-
erations of the cervix, vagina or uterus and uterine rup-
ture. Obstructed labor and unsafe abortions are
common precursors of pregnancy-related hemorrhage.
A number of maternal medical conditions such as dis-
seminated intravascular coagulation, often linked to in-
fection, can also cause hemorrhage [39]. Cesarean
section for prolonged labor can prevent post-partum
hemorrhage due to uterine atony. To reduce risk of
abortion complications, the best preventative strategy is
to have the abortions carried out by skilled practitioners
[40]. If hemorrhage occurs, often due to retained prod-
ucts of conception and sometimes a uterine perforation,
uterine suction or dilation and curettage (D&C) to
evacuate the uterus, blood transfusion, and sometimes
abdominal exploration including hysterectomy are ne-
cessary to save the woman’s life. Most antepartum
hemorrhage is due to either a placental abruption or a
placenta previa and in most cases cesarean section is the
appropriate treatment for both conditions [39]. Most
post-partum hemorrhage is due to an atonic uterus. Use
of uterotonics such as misoprostol or oxytocin, and per-
haps carbetocin, a log-acting and heat stable oxytocin
substitute, given immediately after delivery can prevent
many of the post-partum hemorrhages associated with
an atonic uterus [41]. However, major reductions in
mortality from hemorrhage usually occur with appropri-
ate treatment of hemorrhage once it occurs. Appropriate
treatment depends on the cause of the hemorrhage. As
above, uterotonics and manual compression of the
uterus can reduce ongoing hemorrhage from an atonic
uterus. Manual removal of the placenta, uterine suction
or D&C can treat bleeding due to retained products, and
careful inspection of the vagina and cervix with suturing
when necessary can treat hemorrhage from this cause.
However, in some cases, perhaps due to a uterine rup-
ture or atonic uterus, failure to respond to conventional
treatments can require surgical treatment. Hysterectomy
is often the intervention of last resort for many types of
hemorrhage unresponsive to other types of treatment.
For hemorrhage caused by any of the above conditions,
blood products are often also required to prevent mor-
tality. Given the many causes of hemorrhage, we
emphasize that accurate diagnosis is needed to identify
the appropriate prevention and treatment and therefore,
no single intervention is likely to have a large impact on
hemorrhage-related maternal mortality.
Infection is the generally considered the second most
common cause of maternal death [10]. The most im-
portant causes of infection-related maternal mortality
are the bacterial infections of the uterus and related sep-
sis [41]. The reasons for the high risk of infection post-
partum are not hard to understand. The vagina is not
sterile, and once membranes rupture, vaginal bacteria
have easy access to the recently emptied uterus that pro-
vides an excellent culture medium for bacteria. Historic-
ally, childbed fever often resulted from bacteria
transmitted due to lack of handwashing by birth atten-
dants and was the major cause of maternal mortality
[42]. In addition to the use of non-sterile delivery tech-
niques, unsafe abortion, prolonged labor, and instrumen-
tation including forceps and cesarean section all increase
the risk of infection [40]. Prevention of infection in-
cludes use of sterile techniques at delivery and especially
provider hand washing, avoiding prolonged labors and
reducing instrumentation. Prophylactic antibiotic strat-
egies, especially following cesarean section also prevent
post-partum sepsis. Treatment generally consists of the
timely administration of appropriate antibiotics but may
include D&C to remove infected retained products of
conception and in severe cases, hysterectomy. Malaria,
also an important infectious cause of maternal mortality
in malaria endemic areas, can be responsible for mater-
nal deaths both during acute episodes and increase risk
of maternal anemia [43].
In most studies, the third major cause of maternal
mortality is hypertension [10, 44]. Most maternal deaths
occur following the onset of eclampsia. The causes of
maternal preeclampsia/eclampsia are not known. Reduc-
tion of risk for preeclampsia/eclampsia has been re-
ported with maternal treatment with calcium and low-
dose aspirin, but the percent reductions appear small
and almost certainly [45], these interventions will not
eliminate this problem. The causes of death in women
with preeclampsia and eclampsia include increased pla-
cental abruption and disseminated intravascular coagula-
tion, both leading to hemorrhage, asphyxia, aspiration
pneumonia, strokes, and cardiac, liver and kidney failure.
Preeclampsia is often asymptomatic until seizures or
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other major complications develop. Therefore, diagnosis
through frequent prenatal testing for hypertension and
proteinuria is necessary to diagnose the condition, insti-
tute effective treatment and reduce mortality. Since pre-
eclampsia/eclampsia is most common late in pregnancy
or during the post-partum period, repeated testing dur-
ing those time periods is crucial if cases are not to be
missed. In the end, for progressive disease, the only ef-
fective treatment is delivery, but choosing the appropri-
ate time is often problematic. Delivery too soon
increases the risk of complications of prematurity in the
newborn, while delivery too late increases the risk of
stillbirth and the maternal complications described
above. If delivery is delayed, close monitoring for wors-
ening disease is required. Delivery is often affected by
cesarean section or induction of labor. Antihypertensive
therapy may prevent stroke and magnesium sulfate may
provide time to allow delivery prior to new or recurrent
seizures. Deaths from preeclampsia/eclampsia are nearly
all preventable through prenatal care to diagnose the
condition, hospital referral for close monitoring,
followed by delivery by labor induction or cesarean sec-
tion. Magnesium sulfate treatment may save some lives
but should not be the mainstay of a program to save
lives from preeclampsia and eclampsia [26].
In summary, most maternal deaths can be prevented
through prevention or early diagnosis of the major con-
ditions that cause the deaths and providing appropriate
treatment for those conditions. Since, with a few import-
ant exceptions, most complications leading to maternal
death cannot be predicted or prevented, care for these
conditions must be readily available to all pregnant
women. Most maternal deaths occur during labor, deliv-
ery and in the immediate post-partum period. When the
conditions causing maternal death are considered, it be-
comes clear that the treatments for these conditions
need to be readily available during labor and after deliv-
ery. Few of these interventions are available in the home
and unfortunately, in most low and middle-income
countries, many of these interventions are not available
to women delivering in the clinics. For these reasons,
having all births occur in hospitals that have these inter-
ventions available is the strategy most likely to have the
largest impact on maternal mortality.
Stillbirth
Most stillbirths in low-income countries are attributed to
intrapartum events, often associated with poor care at de-
livery, while intrapartum stillbirths rarely occur in high-
income countries [31, 32]. In low-income countries, most
stillbirths are due to intrauterine asphyxia, followed by in-
fections and congenital anomalies. Many of the maternal
conditions contributing to maternal death also lead to
fetal asphyxia. Prolonged/obstructed labor, preeclampsia/
eclampsia, placental abruption and pregnancy complica-
tions such as growth retardation, abnormal presentations,
and cord complications also increase risk for fetal death
with the final common pathway being asphyxia. Interest-
ingly, while eclampsia is responsible for most maternal
deaths, preeclampsia is most often associated with still-
birth so more intensive monitoring for this condition is
advised [26]. Monitoring the fetus for signs of asphyxia,
usually by assessing the fetal heart rate either during pre-
natal care for fetuses at risk or during labor, can determine
which fetuses are at risk of stillbirth [45]. Cesarean section
for fetuses with heart rate abnormalities or other signs of
fetal distress can prevent many stillbirths.
It has been estimated that 25 to 50% of stillbirths are
caused by infection [16]. The list of organisms that have
been associated with stillbirth is extensive and includes
bacteria, viruses, fungi and many parasites. The inter-
ventions that may prevent an infection-related stillbirth
depend on the organisms involved. Especially in sub-
Saran Africa, syphilis is an important cause of stillbirth
and programs that diagnose and treat maternal syphilis
in that location are important to reduce stillbirth. Mal-
aria causes an unknown number of stillbirths in endemic
areas, especially in sub-Saharan Africa, but the impact of
malaria in these locations is thought to be large. Pre-
venting maternal malaria with bednets and intermittent
prophylaxis are strategies that should reduce malaria-
associated stillbirths. Decreasing prolonged labor to re-
duce bacterial chorioamnionitis, will likely play a role in
reducing stillbirths, but the extent of reduction from this
strategy is unknown. Similarly, appropriate maternal vac-
cination for maternal conditions that cause stillbirths
such as polio, rubella and other childhood diseases
should eliminate some stillbirths. With the possible ex-
ceptions of antibiotic use for Group B streptococcus
(GBS) or membrane rupture, antibiotics have a smaller
role in preventing intrapartum stillbirths.
Neonatal mortality
Neonates die from three major causes in low and middle-
income countries: asphyxia, infection, and conditions re-
lated to preterm birth [20]. Asphyxia is best prevented ra-
ther than treated. Many of the interventions that decrease
maternal mortality and stillbirth also reduce neonatal as-
phyxia. Since placental insufficiency, cord complications,
prolonged labor, abruption and preeclampsia/eclampsia
are the maternal conditions most commonly associated
with neonatal asphyxia, and the stillbirths generally occur
around delivery, fetal monitoring and cesarean section are
the strategies generally used to prevent neonatal asphyxia.
Mild asphyxia present at birth can be effectively treated by
neonatal resuscitation, but newborns with severe birth as-
phyxia generally require extensive treatment beyond re-
suscitation and is often of limited success, especially in
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areas without access to intensive care. We emphasize that
prevention of asphyxia should be one of the main strat-
egies used to reduce neonatal mortality.
Approximately one-third of neonatal mortality is dir-
ectly caused by conditions related to the prematurity it-
self, while another third of neonatal mortality occurs in
preterm infants but is caused by conditions that occur in
both term and preterm infants such as asphyxia, infec-
tion and congenital anomalies. While there are few if
any interventions effective in preventing preterm births,
prevention of conditions associated with mortality
among preterm newborns has been responsible for
much of the remarkable reduction in neonatal mortality
over the last decades. In high income-countries, cortico-
steroids given to the mother in the week prior to deliv-
ery may reduce the risk of RDS by 50%, as well as
decreasing NEC, IVH and neonatal mortality substan-
tially. As a word of caution, in one low-income study,
corticosteroids not only failed to reduce mortality in the
targeted infants but was associated with small increases
in mortality in term infants and an increase in stillbirths
as well [46]. For those neonates with RDS, oxygen, venti-
latory support and surfactant substantially reduce mor-
tality and those interventions, especially oxygen and
CPAP are thought to have contributed the most to the
observed reductions in mortality [34].
Newborn infection is another major cause of mortality.
Much of the neonatal mortality from infection is pre-
ventable. Vaccination of the mother for conditions such
as rubella can prevent neonatal infections resulting in
deaths. Deaths from tetanus can be prevented if the
mother is immunized. Screening the mother for group B
streptococcal infection and treating the mother with an-
tibiotics during labor can reduce much of the neonatal
mortality associated with that organism. Attention to
hand washing and other techniques to prevent neonatal
infection will save many lives. Most important, appropri-
ate use of antibiotics for infants with suspected or con-
firmed infections has the potential to reduce neonatal
mortality substantially.
General recommendations
International organizations have prioritized interven-
tions appropriate for low and middle-income countries
to reduce maternal, fetal, and neonatal mortality. Since
most deaths occur around the time of delivery, the
United Nations has reviewed this information and pro-
moted several strategies to reduce intra-partum mater-
nal, fetal and neonatal mortality [1]. These strategies
include ensuring a skilled birth attendant at delivery, en-
suring prompt access to emergency obstetric care and
having quality neonatal care including resuscitation
available. Ideally, all women would deliver in a facility
with essential obstetric and newborn care including
intrapartum monitoring with early detection and man-
agement or referral to a hospital with advanced capabil-
ities for both maternal and neonatal complications.
Since saving many maternal, fetal and newborn lives re-
quires a cesarean section, access to cesarean section in
low and middle-income countries is crucial to achieve
maternal, fetal and neonatal mortality rates comparable
to those seen in high-income countries [47].
The quality of the providers and their level of skills is
a crucial consideration. Historically, in the absence of a
skilled obstetric provider, maternal mortality approached
1% of all deliveries, rates seen in some low-income
countries today. In many low-income countries, until re-
cently, most often the birth attendant was a traditional
birth attendant (TBA), traditionally a community woman
with little education, but often with practical experience
performing deliveries with the practice handed down
from generation to generation [48]. In most areas served
by TBAs, mortality rates were and remain high. Most
studies have shown that even with additional TBA train-
ing, the maternal mortality rates do not decline [49]. To
reduce those rates close to the levels seen in high-
income countries today, a skilled birth attendant is cru-
cial. For this reason, WHO and other organizations have
recommended the use of skilled attendants for delivery.
However, the training and skills of care-givers designated
as skilled attendants vary widely. Many cannot perform
a cesarean section, give blood or administer antibiotics.
Without these interventions, many women die unneces-
sarily. We should emphasize that even the most skilled
attendant will have little impact on mortality in the ab-
sence of blood, uterotonics or antibiotics, facilities and
equipment necessary to perform a cesarean section or
other life-saving interventions [50].
Another consideration has to do with the quality of
data. Historically, in geographic areas where reductions
in maternal, fetal and neonatal mortality have occurred,
the quality of data has improved as well. In many low
and middle-income countries, one of the major obstacles
to improving pregnancy outcomes is lack of reliable data
on these outcomes. Data that are more difficult to col-
lect, including the causes of death and the coverage for
various prevention or treatment interventions are rarely
available [51]. Without good quality data, the ability for
any treatment facility or geographic area to track their
outcomes over time or compare their outcomes with
similar entities is problematic. Without good data, evalu-
ating the impact of newly introduced programs or inter-
ventions cannot be done. Reliable data are required both
to obtain and to document improvement in care and
pregnancy outcomes.
A great deal of information exists about the medical in-
terventions that if used correctly would reduce maternal,
fetal and neonatal mortality substantially. It is also clear
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that there is no single intervention that will have a great
impact on these outcomes. Instead, a combination of in-
terventions applied at various times during the pregnancy,
and especially during labor and delivery, the post-partum
period and in the neonatal period, are needed to save lives.
Increased access to family planning is of crucial import-
ance. It is also clear that the causes of maternal, fetal and
neonatal deaths are often the same and strategies that
focus on these conditions will likely have an impact on
maternal, fetal and neonatal mortality together [52, 53].
Finally, since many of the conditions that kill mothers, fe-
tuses, and newborns are not easily predicted or prevented,
all women and newborns should have rapid access to the
many known interventions that save lives. For mothers, fe-
tuses and neonates, these interventions are often hospital-
based. Building a system of care by which these interven-
tions can be made available to all women and newborns in
a timely fashion must be accomplished if a low or middle-
income country is to achieve substantial improvement in
its pregnancy outcomes.
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